The Business Times
The Business Times
Subscribe
Share on FacebookShare on TwitterView more
The Business Times
Create a free account with Business Times for seamless access across SPH Media products.
REGISTER
LOGIN

Companies & Markets

SUBSCRIBERS

Teva wins US nod for Actavis after divestiture of 79 drugs

Published Thu, Jul 28, 2016 · 09:50 PM
Share this article.

London

THE US Federal Trade Commission (FTC) has approved Teva Pharmaceutical Industries Ltd's US$40.5 billion purchase of Allergan Plc's generic drug-making unit after the companies agreed to the biggest divestiture ever in a pharmaceutical merger to preserve competition.

The companies agreed to sell 79 existing and future drugs including anaesthetics, antibiotics, weight-loss drugs and oral contraceptives to 11 rival firms to win approval, according to an FTC statement on Wednesday. The divestitures must be completed 10 days after Teva's acquisition of Allergan's generics unit Actavis Inc is co…

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to  t.me/BizTimes

Consumer & Healthcare

SUPPORT SOUTH-EAST ASIA'S LEADING FINANCIAL DAILY

Get the latest coverage and full access to all BT premium content.

SUBSCRIBE NOW

Browse corporate subscription here